- A dictionary of medical eponyms

Douglas A. Jabs


Related eponyms

    American ophthalmologist, born 1951, Elmire, New York

    Biography of Douglas A. Jabs

    David A. Jabs is an expert in clinical research in the fields of ophthalmology and uveitis. He is currently the Chief Executive Officer of the Mount Sinai Faculty Practice Associates, Dean for Clinical Affairs, and Professor and Chair of the Department of Ophthalmology and Professor of Medicine of The Mount Sinai School of Medicine in New York City. Additionally, he is adjunct Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

    Davis A. Jabs graduated valedictorian from Dartmouth College in 1973 with a degree in chemistry. He received his medical degree from Johns Hopkins University School of Medicine in 1977, and his M.D. from the same university. He served internships and residencies in medicine at

    New York Hospital–Cornell Medical Center, The Johns Hopkins Hospital and Wilmer Eye Institute, as well as a rheumatology fellowship at Johns Hopkins.

    Jabs joined the faculty at the Johns Hopkins School of Medicine in 1984 as Assistant Professor. He was named Associate Professor of Ophthalmology in 1988, and Associate Professor of Medicine in 1989. In 1993 he was named Professor of both Ophthalmology and Medicine, and in 2000 he was named Professor of Epidemiology at the Bloomberg School of Public Health. He received a Masters of Science in Business from The John Hopkins University in 1998, and a Masters of Business Administration from The Johns Hopkins in 2000.  He became Chairman of Ophthalmology at the Mount Sinai School of Medicine in March 2007.

    Jabs currently chairs both the Study of Ocular Complications of AIDS (SOCA) Research Group  and the Multicenter Uveitis Steroid Treatment (MUST) Trial. He has chaired five randomized, controlled, clinical trials on the treatment of CMV retinitis and now chairs a multicenter epidemiologic study investigating the long–term outcomes of patients with ocular complications of AIDS, particularly CMV retinitis. Jabs has been instrumental in leading the Standardization of Uveitis (SUN) project, an effort to standardize terminology and outcomes related to uveitis. He has served on numerous data and safety monitoring committees for clinical trials, both those sponsored by the National Institutes of Health and the pharmaceutical industry.

    David A. Jabs is affiliated with several scientific bodies and societies and has received numerous awards.

    Jabs is the author or co–author of over 230 publications, 45 books chapters and 86 published abstracts.

    •    Information from Wikipedia


    D. A. Jabs:
    •  Acyclovir for recurrent herpes simplex virus ocular disease.
       The New England of Medicine, Boston, 1998, 339: 340–341.

    D. A. Jabs, J. T. Rosenbaum, C. S. Foster, G. N. Holland, G J. Jaffe, J. S. Louie, R. B. Nussenblatt, R. E. Stiehm, H. Tessler, R. N. Van Gelder,, S. M. Whitcup, D. Yocum:
    •  Guidelines for the use of immunosuppressive drugs in patients with
        ocular inflammatory disorders:  recommendations of an expert panel.
        American Journal of Ophthalmology, New York, 2000, 130: 492–513.

    D. A. Jabs, A. Mudun, J. P. Dunn, M. J. Marsh:
    •  Episcleritis and scleritis: clinical features and treatment results.
        American Journal of Ophthalmology, New York, 2000, 130: 469–476.

    D. A. Jabs, B. K. Martin, M. S. Forman, L. Hubbard, J. P. Dunn, J. H. Kempen, J. L. Davis, D. V. Weinberg, for the Cytomegalovirus Retinitis and Viral Resistance Study Group:
    •  Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with
        cytomegalovirus retinitis.
        American Journal of Ophthalmology, New York, 2003, 135: 26–34.

    D. A. Jabs, J. T. Holbrook, M. L. Van Natta, R. Clark, M. A. Jacobson, J. H. Kempen, R. L. Murphy, for the Studies of Ocular Complications of AIDS Research Group:
    •  Risk factors for mortality in patients with AIDS in the era of highly active
        antiretroviral therapy.    
        Ophthalmology, New York, 2005, 112: 771–779.

    J. E. Thorne, D. A. Jabs,, G. B. Peters,, Hair D, J. P. Dunn,  J. H. Kempen:
    •  Birdshot retinochoroidopathy: ocular complications and visual impairment.
        American Journal of Ophthalmology, New York, 2005, 140: 45–51.

    • The Standardization of Uveitis Nomenclature (SUN) Working Group.
        Standardization of uveitis  nomenclature for reporting clinical data.
        Results of the first international workshop.
        American Journal of Ophthalmology 2005, 140: 509–516.

    J. E. Thorne, S. E. Wittenberg D. A. Jabs, G. B. Peters, S. R. Kedhar, J. P. Dunn:
    •  Multifocal choroiditis with panuveitis: incidence of ocular complications and
        loss of visual acuity.  Ophthalmology, New York, 2006, 113: 2310–2316.

    J. E. Thorne, D. A. Jabs, S. R. S. R. Kedhar, G. B. Peters,, J. P. Dunn:
    •   Loss of visual field among patients with birdshot chorioretinopathy.
        American Journal of Ophthalmology, New York, 2008, 145: 23–28.

    D. A. Jabs:
    •  AIDS and ophthalmology, 2008.
        Archives of Ophthalmology, Chicago, 2008, 126: 1143–1146.

    A. Galor , D. A. Jabs, H. A. Leder, S. R. Kedhar, J. P. Dunn, J. E. Thorne:
    •  Comparison of antimetabolite drugs as corticosteroid–sparing therapy for
        noninfectious ocular inflammation
        Ophthalmology, New York, 2008, 115:1826–1832.

    J. H. Kempen,, E. Daniel, J. P. Dunn, C. S. Foster, S. Gangaputra, A. Hanish, K. J. Helzlsouer, D. A. Jabs, R. O. Kaçmaz, G. A. Levy–Clarke, T. L. Liesegang, C. W. Newcomb, R. B. Nussenblatt, S. S. Pujari, J. T. Rosenbaum, E. B. Suhler, J. E. Thorne:
    •  Overall and cancer related mortality among patients with ocular inflammation
        treated with     immunosuppressive therapy: retrospective cohort study.
        British Medical Journal, London, 2009, 339: b2480.

    D. A. Jabs, B. K. Martin BK, M. S. Forman, for the Cytomegalovirus Retinitis and Viral Resistance Research Group:
    •  Mortality associated with resistant cytomegalovirus among patients with
        cytomegalovirus retinitis and AIDS. Ophthalmology.


    What is an eponym?

    An eponym is a word derived from the name of a person, whether real or fictional. A medical eponym is thus any word related to medicine, whose name is derived from a person.

    What is Whonamedit?

    Whonamedit.com is a biographical dictionary of medical eponyms. It is our ambition to present a complete survey of all medical phenomena named for a person, with a biography of that person.


    Whonamedit? does not give medical advice.
    This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.